IN2014MN00850A - - Google Patents
Info
- Publication number
- IN2014MN00850A IN2014MN00850A IN850MUN2014A IN2014MN00850A IN 2014MN00850 A IN2014MN00850 A IN 2014MN00850A IN 850MUN2014 A IN850MUN2014 A IN 850MUN2014A IN 2014MN00850 A IN2014MN00850 A IN 2014MN00850A
- Authority
- IN
- India
- Prior art keywords
- methyl
- compound
- formula
- preparation
- methoxy group
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/62—Carboxylic acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C67/00—Preparation of carboxylic acid esters
- C07C67/30—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group
- C07C67/313—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by introduction of doubly bound oxygen containing functional groups, e.g. carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
- C07C69/67—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of saturated acids
- C07C69/716—Esters of keto-carboxylic acids or aldehydo-carboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/34—One oxygen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
- C12P17/10—Nitrogen as only ring hetero atom
- C12P17/12—Nitrogen as only ring hetero atom containing a six-membered hetero ring
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Microbiology (AREA)
- Genetics & Genomics (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN850MUN2014 IN2014MN00850A (th) | 2011-10-19 | 2012-10-19 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN2943MU2011 | 2011-10-19 | ||
| IN850MUN2014 IN2014MN00850A (th) | 2011-10-19 | 2012-10-19 | |
| PCT/GB2012/000798 WO2013057468A1 (en) | 2011-10-19 | 2012-10-19 | Process for the preparation of an endothelin receptor antagonist |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2014MN00850A true IN2014MN00850A (th) | 2015-04-17 |
Family
ID=47116083
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN850MUN2014 IN2014MN00850A (th) | 2011-10-19 | 2012-10-19 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20140256004A1 (th) |
| EP (1) | EP2768811A1 (th) |
| JP (1) | JP2015502916A (th) |
| KR (1) | KR20140091700A (th) |
| AU (1) | AU2012324612A1 (th) |
| BR (1) | BR112014009437A2 (th) |
| CA (1) | CA2852810A1 (th) |
| IN (1) | IN2014MN00850A (th) |
| WO (1) | WO2013057468A1 (th) |
| ZA (1) | ZA201403245B (th) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103709106A (zh) * | 2013-12-06 | 2014-04-09 | 石家庄博策生物科技有限公司 | 一种立体选择性制备安立生坦的方法 |
| US9133488B2 (en) | 2013-12-30 | 2015-09-15 | University Of Alaska Fairbanks | Synthetic methods and compounds related thereto |
| CN106011194A (zh) * | 2016-06-14 | 2016-10-12 | 西安大唐制药集团有限公司 | 一种安立生坦的制备方法 |
| CN110437063B (zh) * | 2018-05-03 | 2022-04-29 | 常州恒邦药业有限公司 | 安立生坦关键中间体的制备方法 |
| CN111057725B (zh) * | 2019-07-01 | 2023-08-18 | 弈柯莱生物科技(上海)股份有限公司 | 酮还原酶在制备(s)-1,1-二(4-氟苯基)-2-丙醇的用途及制备 |
| CN110423741B (zh) * | 2019-07-16 | 2021-08-17 | 浙江工业大学 | 羰基还原酶-辅酶nadp+共固定化酶及其制备与应用 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19533023B4 (de) | 1994-10-14 | 2007-05-16 | Basf Ag | Neue Carbonsäurederivate, ihre Herstellung und Verwendung |
| EP0918090A3 (en) | 1997-11-04 | 2002-08-28 | Eli Lilly And Company | Ketoreductase gene and protein from yeast |
| DE19850301A1 (de) | 1998-10-30 | 2000-05-04 | Basf Ag | Verfahren zur Racematspaltung von 2-Hydroxypropionsäuren |
| US7629157B2 (en) | 2003-08-11 | 2009-12-08 | Codexis, Inc. | Ketoreductase polypeptides and related polynucleotides |
| EP2350024A4 (en) * | 2008-11-05 | 2012-03-21 | Msn Lab Ltd | IMPROVED METHOD FOR THE PRODUCTION OF ENDOTHELIN RECEPTOR ANTAGONISTS |
| WO2010091877A2 (en) | 2009-02-13 | 2010-08-19 | Ratiopharm Gmbh | Process for producing ambrisentan |
| EP2712865B1 (en) * | 2009-07-10 | 2016-03-16 | Cadila Healthcare Limited | Improved process for the preparation of ambrisentan |
-
2012
- 2012-10-19 JP JP2014536322A patent/JP2015502916A/ja active Pending
- 2012-10-19 CA CA2852810A patent/CA2852810A1/en not_active Abandoned
- 2012-10-19 BR BR112014009437A patent/BR112014009437A2/pt not_active Application Discontinuation
- 2012-10-19 KR KR1020147013040A patent/KR20140091700A/ko not_active Application Discontinuation
- 2012-10-19 WO PCT/GB2012/000798 patent/WO2013057468A1/en active Application Filing
- 2012-10-19 AU AU2012324612A patent/AU2012324612A1/en not_active Abandoned
- 2012-10-19 IN IN850MUN2014 patent/IN2014MN00850A/en unknown
- 2012-10-19 EP EP12780256.9A patent/EP2768811A1/en not_active Withdrawn
- 2012-10-19 US US14/352,917 patent/US20140256004A1/en not_active Abandoned
-
2014
- 2014-05-06 ZA ZA2014/03245A patent/ZA201403245B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP2015502916A (ja) | 2015-01-29 |
| CA2852810A1 (en) | 2013-04-25 |
| US20140256004A1 (en) | 2014-09-11 |
| ZA201403245B (en) | 2015-06-24 |
| EP2768811A1 (en) | 2014-08-27 |
| BR112014009437A2 (pt) | 2017-04-11 |
| AU2012324612A1 (en) | 2014-05-15 |
| KR20140091700A (ko) | 2014-07-22 |
| WO2013057468A1 (en) | 2013-04-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12016501375A1 (en) | Pyridin-2-amides useful as cb2 agonists | |
| CR20140237A (es) | Procedimiento de preparación de 5-fluoro-1h-pirazolopiridinas sustituidas | |
| AU2012313888A8 (en) | 3-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant IDH | |
| ECSP12011581A (es) | Inhibidores de bace | |
| UA110354C2 (uk) | Противірусні сполуки | |
| IN2014MN02496A (th) | ||
| IN2014MN01521A (th) | ||
| EP2590649A4 (en) | PROCESS FOR SYNTHESIS OF SUBSTITUTED MORPHINANES | |
| IN2014DN00144A (th) | ||
| MX2013011257A (es) | Proceso para la preparacion de dronedarona por n-butilacion. | |
| MX2013015308A (es) | Inhibidores de proteasoma y procesos para su preparacion, purificacion y uso. | |
| IN2014MN00850A (th) | ||
| IN2014CN00302A (th) | ||
| MX2014002446A (es) | Compuestos de ciclohexano sustituidos novedosos. | |
| JO3063B1 (ar) | مركب مبتكر وطرق لانتاجه | |
| IN2014DN06192A (th) | ||
| GB201107985D0 (en) | Process | |
| MX2013000294A (es) | Intermedios y procedimiento de preparación de un inhibidor específico de la trombina. | |
| MY164880A (en) | Process for the preparation of isoxazolyl-methoxy-nicotinic acids | |
| MX2013013262A (es) | Derivados de ciclododecadienona como ingredientes de perfumado. | |
| MY160625A (en) | Process for preparing pan-cdk inhibitors of the formula(i), and intermediates in the preparation | |
| ME00929B (me) | NOVI POSTUPAK ZA DOBlJANJE KRISTALNOG OBLIKA V AGOMELATIN A | |
| IN2014DN03245A (th) | ||
| MX2014002378A (es) | Proceso para la preparacion de (r)-2-acetamido-n-bencil-3-metoxipr opionamida e intermediarios de la misma. | |
| JO3200B1 (ar) | طريقة ونواتج وسيطة لتحضير أجوميلاتين |